During the past decade, FGM-Clinica Paulista de Doencas Cardiovasculares conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 5 clinical trials were completed, i.e. on average, 500% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 3 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "FGM-Clinica Paulista de Doencas Cardiovasculares" #1 collaborator was "Eli Lilly and Company" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "FGM-Clinica Paulista de Doencas Cardiovasculares" are "Cardiovascular Disease" (2 trials), "Atrial Fibrillation" (1 trials), "Dyslipidemia" (1 trials), "Heart Failure" (1 trials) and "Hypercholesterolemia" (1 trials). Many other conditions were trialed in "FGM-Clinica Paulista de Doencas Cardiovasculares" in a lesser frequency.

Most popular intervention types in "FGM-Clinica Paulista de Doencas Cardiovasculares" are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "bococizumab (PF-04950615)" (2 trials), "Empagliflozin" (1 trials), "Rosuvastatin 10 mg + Ezetimibe 10 mg and Rosuvastatin 20 mg + Ezetimibe 10 mg, according to clinical evaluation." (1 trials) and "Simvastatin 20 mg + Ezetimibe 10 mg and Simvastatin 40 mg + Ezetimibe 10 mg, according to clinical evaluation." (1 trials). Other intervention names were less common.

The vast majority of trials in "FGM-Clinica Paulista de Doencas Cardiovasculares" are 5 trials for "All" genders.

Currently, there are NaN active trials in "FGM-Clinica Paulista de Doencas Cardiovasculares". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in FGM-Clinica Paulista de Doencas Cardiovasculares, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in FGM-Clinica Paulista de Doencas Cardiovasculares, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".